Oyeniyi Diya
Marlow, ENG SL71YL, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and Immunogenicity of the BNT162b2 COVID-19 Vaccine in Immunocompromised Participants 2 Years and Older: Results of an Open-Label Phase 2b Study.
Journal: Vaccines
Published: April 03, 2026
Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial.
Journal: Infectious diseases and therapy
Published: March 07, 2025
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years Old.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 06, 2025
Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 06, 2025
A phase 2/3 trial to investigate the safety and immunogenicity of monovalent Omicron JN.1-adapted BNT162b2 COVID-19 vaccine in adults ≥18 years old.
Journal: Vaccine
Published: September 30, 2024
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial.
Journal: Vaccines
Published: December 19, 2023
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years.
Journal: The New England journal of medicine
Published: January 18, 2023
A Case of Small Bowel Obstruction and Enterocutaneous Fistulation Resulting from a Mesenteric Haematoma following Blunt Abdominal Trauma.
Journal: Case reports in surgery
Published: June 27, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026